SynthesisFrontiers in digital health2025
Effectiveness of mobile health in symptom management of prostate cancer patients: a systematic review and meta-analysis.
Synthesis in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The impact of digital interactive interventions on survivorship outcomes in prostate cancer: a systematic narrative review.BMC cancer · 2025Pooled it
- A mobile health app for real-time symptom monitoring in patients with cancer during COVID-19: feasibility, acceptability, and utility.BMC cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mobile health (mHealth) is an accessible strategy to deliver health information and is becoming increasingly popular as a form of follow-up among medical staff. However, the effects of mobile health on the physical and mental health outcomes of patients with prostate cancer after discharge from the hospital remain unclear. This meta-analysis evaluated the current evidence regarding the effects of mHealth interventions on the outcomes of patients with prostate cancer. Methods: Four databases (PubMed, Cochrane Central electronic database, EMBASE, and Web of Science) were searched from inception to 8 November 2024 for randomized controlled trials (RCTs) comparing the effects of mobile health vs. usual care on the outcomes of patients with prostate cancer. Pooled outcome measures were determined using random effects models. Results: In total, 11 RCTs, including 1,368 patients, met the criteria for inclusion in this meta-analysis. The meta-analysis revealed a significant effect of mHealth interventions on long-term bowel function outcomes (standard mean difference = 0.19, 95% confidence interval = 0.01-0.37, Conclusions: mHealth interventions can significantly improve long-term bowel function outcomes. However, more research is needed to confirm other physical and mental health outcomes. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, PROSPERO (CRD420250651320).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.